-
1.Trisubstituted naphthylalkylamides for disorders of the melatoninergic system 失效
标题翻译: 用于褪黑激素系统疾病的三取代萘基烷基酰胺公开(公告)号:US5591775A
公开(公告)日:1997-01-07
申请号:US349914
申请日:1994-12-06
申请人: Patrick Depreux , Hamid A. Mansour , Daniel Lesieur , Fran.cedilla.ois Lefoulon , Pierre Renard , Gerard Adam , Philippe Delagrange
发明人: Patrick Depreux , Hamid A. Mansour , Daniel Lesieur , Fran.cedilla.ois Lefoulon , Pierre Renard , Gerard Adam , Philippe Delagrange
IPC分类号: A61K31/165 , A61K31/17 , A61K31/18 , A61K31/215 , A61K31/22 , A61P1/00 , A61P3/04 , A61P9/00 , A61P25/20 , A61P25/24 , A61P25/26 , C07C231/12 , C07C233/18 , C07C233/25 , C07C233/31 , C07C233/60 , C07C233/61 , C07C273/18 , C07C275/24 , C07C275/26 , C07C327/42 , C07C327/46 , A61K31/16 , C07C275/06 , C07C335/06
CPC分类号: C07C233/31 , C07C233/18 , C07C233/60 , C07C233/61 , C07C275/24 , C07C275/26 , C07C327/42 , C07C327/46 , C07C2101/02 , C07C2101/04 , C07C2101/08 , C07C2101/14 , C07C2101/16
摘要: The invention relates to a compound selected from those of formula (I): ##STR1## in which R, R.sub.1, R.sub.2 and R.sub.3 are as defined herein for use in the treatment of a disorder of the melatoninergic system.
摘要翻译: 本发明涉及选自式(I)的化合物:其中R,R 1,R 2和R 3如本文所定义,用于治疗褪黑激素系统病症。
-
公开(公告)号:US5512569A
公开(公告)日:1996-04-30
申请号:US408069
申请日:1995-03-21
申请人: Hamid A. Mansour , Thierry Taverne , Raymond Houssin , Isabelle Lesieur , Patrick Depreux , Geard Adam , Daniel-Henri Caignard , Pierre Renard , Marie-Claire Rettori
发明人: Hamid A. Mansour , Thierry Taverne , Raymond Houssin , Isabelle Lesieur , Patrick Depreux , Geard Adam , Daniel-Henri Caignard , Pierre Renard , Marie-Claire Rettori
IPC分类号: A61K31/425 , A61K31/428 , A61K31/445 , A61K31/495 , A61K31/535 , A61K31/54 , A61P25/00 , A61P25/18 , A61P25/20 , A61P25/24 , A61P25/26 , A61P43/00 , C07D277/68 , C07D417/02
CPC分类号: C07D277/68
摘要: The invention relates to the compounds of formula (I): ##STR1## in which R.sub.1 and R.sup.2 are as defined in the description, the optical isomers thereof,and an addition salt thereof with a pharmaceutically-acceptable acid or base, and medicinal product useful for treating a mammal afflicted with a disease associated with sigma receptors.
摘要翻译: 本发明涉及式(I)化合物:其中R 1和R 2如说明书中所定义,其光学异构体及其与药学上可接受的酸或碱的加成盐,和 用于治疗患有与σ受体相关的疾病的哺乳动物的药用产品。
-